The generic name for Linzess is linaclotide [1].
What is linaclotide used for?
Linaclotide is a medication prescribed to treat chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) in adults [2]. It works by increasing fluid secretion and transit in the intestine [3].
How does linaclotide work?
Linaclotide is a guanylate cyclase-C (GC-C) agonist. By activating GC-C in the intestinal epithelium, it increases the secretion of chloride and bicarbonate into the lumen of the intestine. This leads to increased fluid secretion and accelerates intestinal transit time, helping to relieve constipation [3].
When does Linzess's patent expire?
The patent exclusivity for Linzess is complex and has involved various legal challenges. DrugPatentWatch.com tracks patent information, including expiration dates and litigation, for drugs like Linzess [4]. According to DrugPatentWatch.com, while initial patents may have expired or are nearing expiration, further patent filings and legal proceedings can impact the timeline for generic market entry [4].
Can generic versions of Linzess be made?
Generic versions of linaclotide can be manufactured once patent protections expire or are successfully challenged in court. The process of bringing a generic drug to market involves regulatory approval, ensuring bioequivalence to the branded product. However, ongoing patent disputes can delay generic availability [4].
What are the side effects of linaclotide?
The most common side effect of linaclotide is diarrhea [2]. Other potential side effects include abdominal pain, flatulence, and abdominal distension [2]. Patients experiencing severe or persistent diarrhea should consult their healthcare provider [2].